Technical Analysis for KMPH - KemPharm, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 9.48 | 8.84% | 0.77 |
KMPH closed up 8.84 percent on Friday, February 26, 2021, on 1.44 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Historical KMPH trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Support | Bullish | 0.00% | |
20 DMA Support | Bullish | 0.00% | |
Crossed Above 50 DMA | Bullish | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Spinning Top | Other | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Fell Below 50 DMA | Bearish | 8.84% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Trending on StockTwits | about 2 hours ago | |
Trending on StockTwits | 2 days ago | |
Trending on StockTwits | 3 days ago | |
Trending on StockTwits | 4 days ago | |
Trending on StockTwits | 5 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs in the United States. Its product candidate includes KP415 and KP484 for the treatment of attention deficit hyperactivity disorder; and KP879 for the treatment of stimulant use disorder. The company also provides APADAZ, an immediate-release combination product candidate of benzhydrocodone and acetaminophen to treat the short-term management of acute pain. It has a collaboration agreement with KVK-Tech, Inc. to manufacture and commercialize APADAZ. The company was founded in 2006 and is headquartered in Celebration, Florida.
Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Pharmaceutical Pain Drugs Psychoactive Drugs Psychiatric Diagnosis Attention Deficit Attention Deficit Hyperactivity Disorder Amphetamine Paracetamol Treatment Of Attention Deficit Hyperactivity Disorder Childhood Psychiatric Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Pharmaceutical Pain Drugs Psychoactive Drugs Psychiatric Diagnosis Attention Deficit Attention Deficit Hyperactivity Disorder Amphetamine Paracetamol Treatment Of Attention Deficit Hyperactivity Disorder Childhood Psychiatric Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 22.08 |
52 Week Low | 0.67 |
Average Volume | 2,097,781 |
200-Day Moving Average | 8.50 |
50-Day Moving Average | 8.69 |
20-Day Moving Average | 8.85 |
10-Day Moving Average | 9.91 |
Average True Range | 1.27 |
ADX | 20.28 |
+DI | 30.21 |
-DI | 23.75 |
Chandelier Exit (Long, 3 ATRs ) | 7.93 |
Chandelier Exit (Short, 3 ATRs ) | 9.68 |
Upper Bollinger Band | 11.95 |
Lower Bollinger Band | 5.75 |
Percent B (%b) | 0.6 |
BandWidth | 70.03 |
MACD Line | 0.44 |
MACD Signal Line | 0.41 |
MACD Histogram | 0.0341 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 12.14 | ||||
Resistance 3 (R3) | 12.07 | 11.12 | 11.69 | ||
Resistance 2 (R2) | 11.12 | 10.44 | 11.15 | 11.54 | |
Resistance 1 (R1) | 10.30 | 10.03 | 10.71 | 10.37 | 11.40 |
Pivot Point | 9.35 | 9.35 | 9.56 | 9.38 | 9.35 |
Support 1 (S1) | 8.53 | 8.67 | 8.94 | 8.60 | 7.56 |
Support 2 (S2) | 7.58 | 8.26 | 7.61 | 7.42 | |
Support 3 (S3) | 6.76 | 7.58 | 7.27 | ||
Support 4 (S4) | 6.83 |